CRSP Financials
Crispr Therapeutics AG - Financial statements & key metrics
Stock Price
$56.52
Market Cap
$5.42B
P/E Ratio
-13.0
EPS
$-5.54
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$37.31M
Gross Profit
-
Operating Income
-
Net Income
$-366.25M
EPS (Diluted)
$-4.34
Balance Sheet Highlights
Total Assets
$2.24B
Total Liabilities
$309.95M
Shareholders Equity
-
Cash & Equivalents
$298.26M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-142.77M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-14854.8%
ROE
-25.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CRSP revenue?
CRSP's most recent quarterly revenue was $37.31M. Annual revenue can be calculated by summing the four most recent quarters.
Is CRSP profitable?
CRSP reported a loss of $366.25M in the most recent quarter.
What is CRSP market cap?
CRSP has a market capitalization of $5.42B, making it a mid-cap stock.
Does CRSP have debt?
View CRSP's balance sheet for debt information.
What is CRSP cash flow?
Cash flow data is available in the full financial statements.